Page last updated: 2024-08-25

selfotel and Body Weight

selfotel has been researched along with Body Weight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haapalinna, A; Jolkkonen, J; Kauppinen, R; Koistinaho, J; Nieminen, L; Puurunen, K; Sivenius, J1
Boast, CA; Gerhardt, SC; Hall, NR; Liebman, JM; Pastor, G1

Other Studies

2 other study(ies) available for selfotel and Body Weight

ArticleYear
Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia.
    European journal of pharmacology, 1999, May-07, Volume: 372, Issue:1

    Topics: Adrenergic alpha-Agonists; Animals; Arterial Occlusive Diseases; Body Weight; Cerebral Arteries; Cerebral Cortex; Cerebral Infarction; Corpus Striatum; Excitatory Amino Acid Antagonists; Imidazoles; Ischemic Attack, Transient; Male; Medetomidine; Neuroprotective Agents; Pipecolic Acids; Quinoxalines; Rats; Rats, Wistar

1999
Behavioral tolerance and sensitization to CGS 19755, a competitive N-methyl-D-aspartate receptor antagonist.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:2

    Topics: Animals; Behavior, Animal; Binding, Competitive; Body Weight; Drug Tolerance; Male; Mice; Motor Activity; Pipecolic Acids; Piperidines; Posture; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter

1988